BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PTEN
,
calcium channel activity
,
Ischemia
,
Adipose tissue
,
Laryngoscope
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SRC- 3
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
Prostate epithelial cancer cells overexpressing MYC, HRAS G12V, SRC, or ERBB2 mutant NeuT
NIH3T3 embryonic fibroblasts with c-src[Y527F] mutant
Uterine tissues obtained from SRC-2 (f/f) control and SRC-2 (d/d) conditional knockout mice
Explore Curated Studies Results
Literature
Most Relevant Literature
Nuclear receptor coactivator 3 transactivates proinflammatory cytokines in collagen-induced arthriti…
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Aib1 deficiency exacerbates inflammatory responses in acute myocardial infarction mice.
NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways.
SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family
Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction
SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition …
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Canc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ